Primary Progressive Aphasia Multicomponent Language Treatment Study
Establishing Evidence-based Multicomponent Treatment for Speech and Language in Primary Progressive Aphasia
1 other identifier
interventional
21
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of dementia that affects speech and language. The study will also document how acceptable and helpful the program is for both patients and their care partners. The main questions the study aims to answer are:
- Take part in online speech-language therapy sessions
- Complete communication tasks and questionnaires before and after the program
- Have regular virtual check-ins with the research team
- Include their care partners in some parts of the program for training and support
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2023
CompletedFirst Submitted
Initial submission to the registry
October 16, 2024
CompletedFirst Posted
Study publicly available on registry
October 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedOctober 8, 2025
September 1, 2025
2.7 years
October 16, 2024
October 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in script production accuracy
Percent correct intelligible, scripted words for trained/untrained scripts
change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment
Change in spoken naming of trained/untrained items
Percent correctly named trained/untrained pictures
change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment
Information communicated in any modality for trained/untrained stimuli
Percent of major content units (key words) communicated via speech or nonspeech modalities (e.g., writing, drawing, gesture) for trained/untrained scripts (Multi-VISTA) or words (Multi-LRT) during structured probes and in conversation
change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment
Goal Attainment Score
The Goal Attainment Score is self-reported progress on personalized goals based on a five point scale.
change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment
Secondary Outcomes (2)
Change on Quick Aphasia Battery
change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment
Change on Aphasia Impact Questionnaire
change from pre-treatment to post-treatment (approximately 6-12 weeks after treatment onset) and follow-ups at 3 months post-treatment
Other Outcomes (1)
Post-treatment Communication Survey
post-treatment (approximately 6-12 weeks after treatment onset)
Study Arms (3)
Multicomponent Lexical Retrieval Training (Multi-LRT)
EXPERIMENTALMulticomponent Video Implemented Script Training in Aphasia (Multi-VISTA)
EXPERIMENTALExperimental: Multicomponent Communicaiton Partner Training (Multi-CPT)
EXPERIMENTALInterventions
In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing names of personally relevant target in multiple communication modalities. Treatment focuses on the use of strategies which capitalize on residual linguistic ability and autobiographical memory to support word retrieval. The participant completes two one-hour-long sessions per week plus daily homework. The participant also meets 4 times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.
In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing personally relevant scripts of 3-5 sentences in length. Length and complexity of scripts are individually tailored. The participant completes 30 minutes per day of home practice, during which they speak in unison with a video/audio model of a healthy speaker clearly articulating the scripts. Biweekly (one hour each) sessions with a clinician are held which target clear and accurate script production, script memorization, and conversational usage of the script and multimodal communication. The participant also meets 6 times during the course of treatment with a study partner (e.g., spouse) for communication counseling, education, and practice of communication strategies.
In person or via teletherapy: A multi-component treatment incorporating elements of compensatory and care-partner focused interventions. Biweekly (one hour each) sessions with a clinician are held which target use of communication strategies including multimodal communication for the participant and study partner (e.g., spouse). The participant also completes regular assignments meant to increase generalization of communication strategies and progress on personal goals.
Eligibility Criteria
You may qualify if:
- Meets diagnostic criteria for Primary Progressive Aphasia (PPA; Gorno-Tempini et al., 2011)
- Scores of 10 or higher on the Mini-Mental State Examination
- Has a study partner who can consistently attend sessions
You may not qualify if:
- Other neurological or psychiatric diagnosis that may contribute to cognitive-linguistic deficits
- Significant, uncorrected visual or hearing impairment that would interfere with participation
- Score of less than 10 on the Mini-Mental State Examination
- Prominent initial non-speech-language impairment (cognitive, behavioral, motoric)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas
Austin, Texas, 78712, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maya L Henry, PhD
University of Texas at Austin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 16, 2024
First Posted
October 18, 2024
Study Start
May 2, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
October 8, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share